Companies/US/VRAX

VIRX BIOLPAR

Last · NASDAQ$1.674+0.024 (+1.45%)live · yahoo · 3h ago
Vol 23.4K ≈ 39.1K
Market cap$2.25M1.3M sh
P/E · TTM-0.1fwd -0.3 · eps -12.22 · loss
Beta1.39vs S&P 500
Div yield0.00%annual · TTM
52w range
$1.61$21.75
Volume23.4Ksession

Issuer

Legal nameVIRX BIOLPAR
HQUnited States (US)
ListingUS VRAX
ISINKYG9495L1335
SectorHealthcare
IndustryBiotechnology & Medical Research
SIC2835
CurrencyUSD
Entity registrysec:0001885827
CIK0001885827
Employees19
AddressVirax Biolabs Group Ltd. Bo'Ness Road Newhouse ML1 5UH, Lanarkshire
Loading chart…

OpenFilings analyst

Our analyst

20-F · 2026-07-06

From latest 20-F · 2026-07-06

  • Operating Cf Burn
  • Net Margin Sharply Negative
  • Cash Conversion Weak
  • Cash Runway Low
  • Accumulated Deficit High
  • Rd Intensity High

Red flags

  • Operating Cf Burn — Negative operating cash flow
  • Net Margin Sharply Negative — Net margin -40439.1%
  • Cash Conversion Weak — Cash conversion (CFO/Rev) -37204.3%
  • Cash Runway Low — Cash runway ~1.4 years
  • Accumulated Deficit High — Accumulated deficit / equity 391%
  • Rd Intensity High — R&D/Revenue 30092.2%

Documents

FormReporting forFiledFlags
—2026-10-090
—2026-09-040
—2026-08-180